Neo tect kit, Neospect(depreotide)
Neo Tect, NeoSpect (depreotide) is a protein pharmaceutical. Depreotide was first approved as Neo tect kit on 1999-08-03. It has been approved in Europe to treat radionuclide imaging.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
diagnosis | D003933 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Technetium tc-99m depreotide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NEO TECT KIT | CIS Bio International | N-021012 DISCN | 1999-08-03 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
---|---|
A9536 | Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries |
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | DEPREOTIDE |
INN | depreotide |
Description | Depreotide is an oligopeptide. |
Classification | Protein |
Drug class | peptides: inhibition of growth hormone release |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](CCSCC(=O)NC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O |
Identifiers
PDB | — |
CAS-ID | 161982-62-3 |
RxCUI | — |
ChEMBL ID | CHEMBL1908335 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | NDP0H8E844 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 114 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more